Cargando…

Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis

BACKGROUND: At present, novel coronavirus disease 2019 (COVID-19) has become a serious global public health problem. The current meta-analysis aimed to find risk factors for the COVID-19-related death, helping to enhance the efficacy and reduce the mortality of COVID-19. METHODS: We searched PubMed,...

Descripción completa

Detalles Bibliográficos
Autores principales: Qiu, Peishan, Zhou, Yunjiao, Wang, Fan, Wang, Haizhou, Zhang, Meng, Pan, Xingfei, Zhao, Qiu, Liu, Jing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391922/
https://www.ncbi.nlm.nih.gov/pubmed/32734576
http://dx.doi.org/10.1007/s40520-020-01664-3
_version_ 1783564746831691776
author Qiu, Peishan
Zhou, Yunjiao
Wang, Fan
Wang, Haizhou
Zhang, Meng
Pan, Xingfei
Zhao, Qiu
Liu, Jing
author_facet Qiu, Peishan
Zhou, Yunjiao
Wang, Fan
Wang, Haizhou
Zhang, Meng
Pan, Xingfei
Zhao, Qiu
Liu, Jing
author_sort Qiu, Peishan
collection PubMed
description BACKGROUND: At present, novel coronavirus disease 2019 (COVID-19) has become a serious global public health problem. The current meta-analysis aimed to find risk factors for the COVID-19-related death, helping to enhance the efficacy and reduce the mortality of COVID-19. METHODS: We searched PubMed, Embase, medRxiv, and Cochrane Library for articles published between January 1, 2020, and April 13, 2020. We statistically analyzed the risk factors of the COVID-19 deceased with meta-analysis. RESULTS: A total of 2401 patients in 15 articles were included in this study. Meta-analysis showed that 66.6% of COVID-19 deceased were male, with a median age of 69.9 years. Common symptoms of deceased included fever (70.6–100%), dyspnea (38.89–85.7%), cough (22.4–78%), and fatigue (22–61.9%). The incidence of hypertension, chronic cardiovascular disease, diabetes, and chronic cerebrovascular disease among the COVID-19 deceased were 38.56% (95% confidence interval (CI) 25.84 ~ 52.12%), 17.54% (95% CI 13.38 ~ 21.69%), 22.2% (95% CI 19.30 ~ 25.10%), and 15.58% (95% CI 10.05 ~ 21.12%), respectively. Compared with the surviving COVID-19 patients, the deceased had lower platelet levels (mean difference (MD) = − 39.35, 95% CI − 55.78 ~ − 22.93) and higher C-reactive protein (CRP) (MD = 80.85, 95% CI 62.53 ~ 99.18) and lactate dehydrogenase (LDH) (MD = 246.65, 95% CI 157.43 ~ 335.88) at admission. The most common complications of the deceased were acute respiratory distress syndrome (ARDS) (OR = 100.36, 95% CI 64.44 ~ 156.32) and shock (OR = 96.60, 95% CI 23.80 ~ 392.14). CONCLUSION: Most of the COVID-19 deceased were elderly males. Fever, dyspnea, dry cough, fatigue, hypertension, chronic cardiovascular and cerebrovascular disease, diabetes, and laboratory examinations showed low levels of platelet content, increased CRP and LDH were associated with the risk of dying. ARDS and shock were risk factors for death in COVID-19 patients.
format Online
Article
Text
id pubmed-7391922
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-73919222020-07-31 Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis Qiu, Peishan Zhou, Yunjiao Wang, Fan Wang, Haizhou Zhang, Meng Pan, Xingfei Zhao, Qiu Liu, Jing Aging Clin Exp Res Review BACKGROUND: At present, novel coronavirus disease 2019 (COVID-19) has become a serious global public health problem. The current meta-analysis aimed to find risk factors for the COVID-19-related death, helping to enhance the efficacy and reduce the mortality of COVID-19. METHODS: We searched PubMed, Embase, medRxiv, and Cochrane Library for articles published between January 1, 2020, and April 13, 2020. We statistically analyzed the risk factors of the COVID-19 deceased with meta-analysis. RESULTS: A total of 2401 patients in 15 articles were included in this study. Meta-analysis showed that 66.6% of COVID-19 deceased were male, with a median age of 69.9 years. Common symptoms of deceased included fever (70.6–100%), dyspnea (38.89–85.7%), cough (22.4–78%), and fatigue (22–61.9%). The incidence of hypertension, chronic cardiovascular disease, diabetes, and chronic cerebrovascular disease among the COVID-19 deceased were 38.56% (95% confidence interval (CI) 25.84 ~ 52.12%), 17.54% (95% CI 13.38 ~ 21.69%), 22.2% (95% CI 19.30 ~ 25.10%), and 15.58% (95% CI 10.05 ~ 21.12%), respectively. Compared with the surviving COVID-19 patients, the deceased had lower platelet levels (mean difference (MD) = − 39.35, 95% CI − 55.78 ~ − 22.93) and higher C-reactive protein (CRP) (MD = 80.85, 95% CI 62.53 ~ 99.18) and lactate dehydrogenase (LDH) (MD = 246.65, 95% CI 157.43 ~ 335.88) at admission. The most common complications of the deceased were acute respiratory distress syndrome (ARDS) (OR = 100.36, 95% CI 64.44 ~ 156.32) and shock (OR = 96.60, 95% CI 23.80 ~ 392.14). CONCLUSION: Most of the COVID-19 deceased were elderly males. Fever, dyspnea, dry cough, fatigue, hypertension, chronic cardiovascular and cerebrovascular disease, diabetes, and laboratory examinations showed low levels of platelet content, increased CRP and LDH were associated with the risk of dying. ARDS and shock were risk factors for death in COVID-19 patients. Springer International Publishing 2020-07-30 2020 /pmc/articles/PMC7391922/ /pubmed/32734576 http://dx.doi.org/10.1007/s40520-020-01664-3 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Review
Qiu, Peishan
Zhou, Yunjiao
Wang, Fan
Wang, Haizhou
Zhang, Meng
Pan, Xingfei
Zhao, Qiu
Liu, Jing
Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
title Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
title_full Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
title_fullStr Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
title_full_unstemmed Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
title_short Clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related COVID-19 deceased: a systematic review and meta-analysis
title_sort clinical characteristics, laboratory outcome characteristics, comorbidities, and complications of related covid-19 deceased: a systematic review and meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7391922/
https://www.ncbi.nlm.nih.gov/pubmed/32734576
http://dx.doi.org/10.1007/s40520-020-01664-3
work_keys_str_mv AT qiupeishan clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT zhouyunjiao clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT wangfan clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT wanghaizhou clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT zhangmeng clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT panxingfei clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT zhaoqiu clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis
AT liujing clinicalcharacteristicslaboratoryoutcomecharacteristicscomorbiditiesandcomplicationsofrelatedcovid19deceasedasystematicreviewandmetaanalysis